BioCentury
ARTICLE | Company News

Hisamitsu, Sanofi deal

June 18, 2012 7:00 AM UTC

Sanofi and Hisamitsu will form a 51/49 JV to market OTC allergy medications in Japan. The JV, which will be named Sanofi-Hisamitsu K.K., will be headquartered in Tokyo and will initially have ¥250 mil...